James has held numerous senior executive positions and brings over 35 years of experience in the international biotechnology industry and investment banking. He has previously served as Finance Director for British Biotechnology Group, raising over $300 million and taking the company public in London and on NASDAQ.

Subsequently, he has been a founder and CEO of Avidex Limited, raising $60 million; he also co-founded Immunocore Limited, which has raised in excess of $400 million, and Adaptimmune Therapeutics PLC, raising over $650 million via partnering, private placings, a NASDAQ listing, and subsequent secondary offerings.

He is a non-executive board member at Adaptimmune Therapeutics Deputy Chairman of GW Pharmaceuticals (both NASDAQ-listed) and on the board of private company Celleron Therapeutics; he previously has held non-executive directorships at more than a dozen biotechnology companies.